ArticleJournal of religion and health2026
Retrospective Cohort Study of The Lovelady Center: A large Faith-Based Residential Recovery Program for Women with Substance Use Disorders in the USA.
Article in Journal of religion and health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Lovelady Center in Birmingham, Alabama, is one of the largest residential faith-based recovery programs in the USA for women with substance use disorders and coincident histories of incarceration and/or physical and/or sexual abuse, without the aid of medication-assisted treatment. Presented herein are retrospective analyses of 380 clients within two cohorts for periods of 12 and 24 months, and of 117 respondents to a follow-up questionnaire at 34 months. Cohort I consists of 232 clients (37.6 years' average age) in Phases I through V of the program. Linear regression revealed that the graduation rate (program completion) at 12 months was linear and directly proportional from Phase I to V. The all-cause mortality rate at 24 months revealed that 3.45% of Cohort I clients died. Cohort II consists of 148 previous graduates of the program (39.6 years' average age) who had remained in residence, of whom only 1.35% died within 24 months. A questionnaire completed at 34 months assessed sobriety, sleep, and faith-based parameters. The length of stay was a key predictor of successful completion of the rigorous program with coincident sobriety. The all-cause mortality rate was reduced among those who completed the holistic program.
Indexed as
Identifiers
41973377What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.